おすすめの製品
詳細
Deposition of Amyloid beta (Ab) is an early event in the pathogenesis of Alzheimer s disease (AD). Ab peptides originate from the proteolytic cleavage of the amyloid precursor protein (APP). The beta-secretase cleaves APP between residues Met671 and Asp672 and yields sAPP beta and C99. Following the beta-secretase cleavage, a second cleavage occurs at the C-terminus of Ab peptide that releases Ab from C99. This cleavage occurs in the vicinity of residue 712 of the C-terminus. The gamma-secretase can cleave the C-terminal region at either Val711 or Ile713 to produce the shorter Ab peptide (Ab1-40) or the longer Ab peptide (Ab1-42). Ab1-42 occurs more frequently and forms fibrillar aggregates far more readily than the Ab1-40 peptide. In AD, upregulation of inducible nitric oxide synthase (NOS2), results in tyrosine nitration of several proteins, including Ab, which accelerates its aggregation. APP/PS1/Nlrp3 mice display less nitrated Ab and a reduced average plaque size as well as fewer nitrated plaque cores. NOS2 deficiency and treatment with NOS2 inhibitors is shown to reduce 3NTyr (10)-Ab and overall Ab deposition and cognitive dysfunction in APP/PS1 mice. Also, injection of 3NTyr(10)-A into the brain of young APP/PS1 mice leads to induction of beta-amyloidosis. (Ref.: Heneka, MT et al (2013). Nature 493, 674-678; Kummer, MP et al (2011). Neuron. 71(5):833-844).
特異性
Clone 4A5E8 detects amyloid beta 1-42 nitrated at position 10 in human.
免疫原
Synthetically nitrated linear peptide corresponding to 12 amino acids in the beta amyloid beta 1-42 peptide.
アプリケーション
Research Category
ニューロサイエンス
ニューロサイエンス
Anti-Amyloid Beta 3NTyr10 Antibody, clone 4A5E8, Cat. No. MABN779, is a highly specific mouse monoclonal antibody that targets 3NTyr10 and has been tested in ELISA and Immunohistochemistry.
ELISA Analysis: A representative lot detected Amyloid Beta 3NTyr10 in ELISA applications (Heneka, M.T., et. al. (2013). Nature. 493(7434):674-8).
Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected Amyloid Beta 3NTyr10 in unfixed cortical brain sections from a control verses clinically confirmed AD (Braak stage V) cases. (Courtesy of Dr. Markus Kummer and Prof. Dr. Michael Heneka, MD, University of Bonn, Department of Neurology, Clinical Neurosciences, Germany).
Immunohistochemistry Analysis: A 1:50 dilution from a representative lot detected Amyloid Beta 3NTyr10 in unfixed cortical brain sections from a control verses clinically confirmed AD (Braak stage V) cases. (Courtesy of Dr. Markus Kummer and Prof. Dr. Michael Heneka, MD, University of Bonn, Department of Neurology, Clinical Neurosciences, Germany).
品質
Isotype testing: Identity Confirmation by Isotyping Test.
Isotyping Analysis: The identity of this monoclonal antibody is confirmed by isotyping test to be mouse IgG2b .
Isotyping Analysis: The identity of this monoclonal antibody is confirmed by isotyping test to be mouse IgG2b .
ターゲットの説明
~4.51 kDa calculated. Beta amyloid peptides aggregate in Alzheimer′s disease brain.
物理的形状
Protein G purified
Format: Purified
Purified mouse monoclonal antibody IgG2b in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
保管および安定性
Stable for 1 year at 2-8°C from date of receipt.
その他情報
Concentration: Please refer to lot specific datasheet.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類コード
12 - Non Combustible Liquids
WGK
WGK 2
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
MABN779:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Molecules (Basel, Switzerland), 26(16) (2021-08-28)
Since westernized diet-induced insulin resistance is a risk factor in Alzheimer's disease (AD) development, and lipopolysaccharide (LPS) coexists with amyloid β (Aβ)1-42 in these patients, our AD novel model was developed to resemble sporadic AD by injecting LPS into high
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)